SODIUM DL-.ALPHA.-HYDROXYISOCAPROATE
UNII MMY2KL93K9

Substance Identification & Data

This profile provides standardized clinical and technical data for Sodium Dl-.alpha.-hydroxyisocaproate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) MMY2KL93K9.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 61499-04-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

MMY2KL93K9

CAS Registry Number

61499-04-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SODIUM DL-.ALPHA.-HYDROXYISOCAPROATE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C6H11O3.Na

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

WMPVOYIJOLKBNA-UHFFFAOYSA-M

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

23678826

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C(C(CC(C)C)O)([O-])=O.[Na+]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sodium Dl-.alpha.-hydroxyisocaproate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.